IBRX EPS Estimates
ImmunityBio, Inc.
$10.32
+$0.40(+4.09%)
55
Overall
40
Value
75
Tech
50
Quality
Market Cap
$10.50B
Volume
4.78M
52W Range
$1.95 - $12.43
Target Price
$12.60
IBRX EPS estimates: the consensus estimate for ImmunityBio, Inc.'s current fiscal year is -$0.44 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IBRX EPS Estimates
- EPS estimate, current quarter
- $-0.08
- EPS estimate, next quarter
- $-0.07
- EPS estimate, current year
- $-0.44
- EPS estimate, next year
- $-0.14
- EPS growth, 3-year
- +28.51%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.38 |
| 2024 | $-0.59 |
| 2023 | $-1.15 |
| 2022 | $-1.04 |
| 2021 | $-0.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $10.32 | +4.1% | 4.78M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |